Suppr超能文献

胰腺炎后肝病的频率和危险因素:一项基于人群的队列研究。

Frequency and risk factors for liver disease following pancreatitis: A population-based cohort study.

机构信息

School of Medicine, University of Auckland, Auckland, New Zealand.

Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand.

出版信息

Dig Liver Dis. 2019 Apr;51(4):551-558. doi: 10.1016/j.dld.2018.11.001. Epub 2018 Nov 16.

Abstract

BACKGROUND & AIMS: Both liver disease (LD) and pancreatitis pose substantial burdens. There have been no general population-based studies on frequency of LD after an episode of pancreatitis. The aim of this study was to investigate the occurrence of LD in a population-based cohort of patients following pancreatitis.

METHODS

Nationwide data on the general population of nearly 3 million people were used to identify retrospectively diagnoses of acute pancreatitis, chronic pancreatitis (CP), LD and cirrhosis from 1998 to 2016. Acute pancreatitis was categorised as first (FAP) or recurrent (RAP) episode. Number of pancreatitis recurrences prior to LD diagnosis was determined.

RESULTS

A total of 20,931 pancreatitis patients were included, of which 874 developed LD following pancreatitis. The incidence of LD in FAP was 115.59 (95% confidence interval 102.19-128.98), in RAP - 217.63 (95% confidence interval 173.31-261.94), and in CP - 539.43 (95% confidence interval 494.72-584.13) patients per 100,000 pancreatitis patients per year. There was a significant increase in the probability of LD with increasing number of pancreatitis recurrences and, for the same number of pancreatitis recurrences, LD was significantly more frequent after CP than RAP (hazard ratio 1.666 (95% confidence interval 1.322-2.098; p = <0.001)).

CONCLUSIONS

The frequency of LD increases from FAP to RAP to CP. While number of pancreatitis recurrences is a significant risk factor for development of LD, there is a higher probability of LD following CP than RAP even for the same number of recurrences. Interventions preventing pancreatitis and its progression may lower the burden of LD.

摘要

背景与目的

肝脏疾病(LD)和胰腺炎都带来了巨大的负担。目前还没有基于一般人群的研究调查胰腺炎后 LD 的发病频率。本研究旨在调查基于人群的胰腺炎患者队列中 LD 的发生情况。

方法

利用近 300 万人群的全国性数据,回顾性地从 1998 年至 2016 年诊断出急性胰腺炎、慢性胰腺炎(CP)、LD 和肝硬化。将急性胰腺炎分为首发(FAP)或复发性(RAP)发作。确定 LD 诊断前胰腺炎复发的次数。

结果

共纳入 20931 例胰腺炎患者,其中 874 例在胰腺炎后发生 LD。FAP 的 LD 发生率为 115.59(95%置信区间 102.19-128.98),RAP 为 217.63(95%置信区间 173.31-261.94),CP 为 539.43(95%置信区间 494.72-584.13)例/10 万人/年。随着胰腺炎复发次数的增加,发生 LD 的可能性显著增加,而且对于相同次数的胰腺炎复发,CP 后发生 LD 的可能性明显高于 RAP(风险比 1.666(95%置信区间 1.322-2.098;p<0.001))。

结论

LD 的发病频率从 FAP 增加到 RAP 再增加到 CP。虽然胰腺炎复发次数是发生 LD 的重要危险因素,但即使复发次数相同,CP 后发生 LD 的可能性也高于 RAP。预防胰腺炎及其进展的干预措施可能会降低 LD 的负担。

相似文献

1
Frequency and risk factors for liver disease following pancreatitis: A population-based cohort study.
Dig Liver Dis. 2019 Apr;51(4):551-558. doi: 10.1016/j.dld.2018.11.001. Epub 2018 Nov 16.
3
Risk factors and prediction score for chronic pancreatitis: A nationwide population-based cohort study.
World J Gastroenterol. 2018 Nov 28;24(44):5034-5045. doi: 10.3748/wjg.v24.i44.5034.
4
Outcome of endotherapy for pancreas divisum in patients with acute recurrent pancreatitis.
World J Gastroenterol. 2014 Dec 14;20(46):17468-75. doi: 10.3748/wjg.v20.i46.17468.
5
Impact of recurrent acute pancreatitis on the natural history and progression to chronic pancreatitis.
Pancreatology. 2022 Dec;22(8):1084-1090. doi: 10.1016/j.pan.2022.09.237. Epub 2022 Sep 13.
6
Analysis of lifestyle factors in patients with concomitant chronic pancreatitis and liver cirrhosis.
Pancreatology. 2017 Sep-Oct;17(5):698-705. doi: 10.1016/j.pan.2017.07.194. Epub 2017 Jul 31.
8
Disease progression of acute pancreatitis in pediatric patients.
J Surg Res. 2016 May 15;202(2):422-7. doi: 10.1016/j.jss.2016.01.016. Epub 2016 Jan 20.
9

引用本文的文献

1
Hemosuccus Pancreaticus: Diagnostic Pitfalls of a Rare Condition.
ACG Case Rep J. 2023 Mar 24;10(3):e01014. doi: 10.14309/crj.0000000000001014. eCollection 2023 Mar.
4
Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.
Acta Pharm Sin B. 2020 Mar;10(3):399-413. doi: 10.1016/j.apsb.2019.11.008. Epub 2019 Nov 14.
5
Canine Cancer: Strategies in Experimental Therapeutics.
Front Oncol. 2019 Nov 15;9:1257. doi: 10.3389/fonc.2019.01257. eCollection 2019.

本文引用的文献

4
Myths and realities about alcohol and smoking in chronic pancreatitis.
Curr Opin Gastroenterol. 2018 Sep;34(5):355-361. doi: 10.1097/MOG.0000000000000466.
5
Abdominal obesity and insulin resistance after an episode of acute pancreatitis.
Dig Liver Dis. 2018 Oct;50(10):1081-1087. doi: 10.1016/j.dld.2018.04.023. Epub 2018 May 1.
6
Tobacco and alcohol as risk factors for pancreatic cancer.
Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):529-536. doi: 10.1016/j.bpg.2017.09.001. Epub 2017 Sep 6.
7
Interplay between innate immunity and iron metabolism after acute pancreatitis.
Cytokine. 2018 Mar;103:90-98. doi: 10.1016/j.cyto.2017.09.014. Epub 2017 Oct 2.
8
Chronic pancreatitis in patients with liver cirrhosis negatively affects graft survival after liver transplantation.
Pancreatology. 2017 Nov-Dec;17(6):898-904. doi: 10.1016/j.pan.2017.09.006. Epub 2017 Sep 14.
9
Incidence and risk of acute coronary syndrome in patients with acute pancreatitis: A nationwide cohort study.
Pancreatology. 2017 Sep-Oct;17(5):675-680. doi: 10.1016/j.pan.2017.07.189. Epub 2017 Jul 25.
10
Mechanisms of hepatic stellate cell activation.
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验